Style | Citing Format |
---|---|
MLA | Goleij P, et al.. "Phytostilbenes in Lymphoma: Focuses on the Mechanistic and Clinical Prospects of Resveratrol, Pterostilbene, Piceatannol, and Pinosylvin." Leukemia Research, vol. 138, no. , 2024, pp. -. |
APA | Goleij P, Sanaye PM, Babamohamadi M, Tabari MAK, Amirian R, Rezaee A, Mirzaei H, Kumar AP, Sethi G, Sadreddini S, Jeandet P, Khan H (2024). Phytostilbenes in Lymphoma: Focuses on the Mechanistic and Clinical Prospects of Resveratrol, Pterostilbene, Piceatannol, and Pinosylvin. Leukemia Research, 138(), -. |
Chicago | Goleij P, Sanaye PM, Babamohamadi M, Tabari MAK, Amirian R, Rezaee A, Mirzaei H, et al.. "Phytostilbenes in Lymphoma: Focuses on the Mechanistic and Clinical Prospects of Resveratrol, Pterostilbene, Piceatannol, and Pinosylvin." Leukemia Research 138, no. (2024): -. |
Harvard | Goleij P et al. (2024) 'Phytostilbenes in Lymphoma: Focuses on the Mechanistic and Clinical Prospects of Resveratrol, Pterostilbene, Piceatannol, and Pinosylvin', Leukemia Research, 138(), pp. -. |
Vancouver | Goleij P, Sanaye PM, Babamohamadi M, Tabari MAK, Amirian R, Rezaee A, et al.. Phytostilbenes in Lymphoma: Focuses on the Mechanistic and Clinical Prospects of Resveratrol, Pterostilbene, Piceatannol, and Pinosylvin. Leukemia Research. 2024;138():-. |
BibTex | @article{ author = {Goleij P and Sanaye PM and Babamohamadi M and Tabari MAK and Amirian R and Rezaee A and Mirzaei H and Kumar AP and Sethi G and Sadreddini S and Jeandet P and Khan H}, title = {Phytostilbenes in Lymphoma: Focuses on the Mechanistic and Clinical Prospects of Resveratrol, Pterostilbene, Piceatannol, and Pinosylvin}, journal = {Leukemia Research}, volume = {138}, number = {}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Goleij P AU - Sanaye PM AU - Babamohamadi M AU - Tabari MAK AU - Amirian R AU - Rezaee A AU - Mirzaei H AU - Kumar AP AU - Sethi G AU - Sadreddini S AU - Jeandet P AU - Khan H TI - Phytostilbenes in Lymphoma: Focuses on the Mechanistic and Clinical Prospects of Resveratrol, Pterostilbene, Piceatannol, and Pinosylvin JO - Leukemia Research VL - 138 IS - SP - EP - PY - 2024 ER - |